Wellington Management Group LLP Acquires 53,383 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wellington Management Group LLP raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,115,024 shares of the medical equipment provider's stock after purchasing an additional 53,383 shares during the period. Wellington Management Group LLP owned 0.87% of Intuitive Surgical worth $1,530,318,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the business. Hazlett Burt & Watson Inc. lifted its holdings in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. boosted its position in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after purchasing an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC grew its stake in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock worth $653,000 after purchasing an additional 21 shares during the period. Meeder Advisory Services Inc. raised its holdings in Intuitive Surgical by 0.3% in the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider's stock worth $3,629,000 after purchasing an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC lifted its position in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after buying an additional 23 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Piper Sandler reiterated an "overweight" rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Truist Financial upped their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus price target of $541.33.

Insiders Place Their Bets

In other news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,023 shares of company stock valued at $26,384,247 in the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Up 0.5 %

NASDAQ:ISRG traded up $2.76 on Friday, reaching $550.41. 1,026,203 shares of the company's stock traded hands, compared to its average volume of 1,287,180. The stock has a 50-day simple moving average of $514.78 and a 200-day simple moving average of $472.60. Intuitive Surgical, Inc. has a 12 month low of $307.72 and a 12 month high of $556.23. The firm has a market cap of $196.05 billion, a PE ratio of 88.49, a P/E/G ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.